Quantitative assessment of lung ventilation and microstructure in an animal model of idiopathic pulmonary fibrosis using hyperpolarized gas MRI

Academic Radiology

Volumn 17, Issue 11, 2010, Pages 1433-1443

  Stephen, Michael J ^a   Emami, Kiarash ^a   Woodburn, John M ^a   Chia, Elaine ^a   Kadlecek, Stephen ^a   Zhu, Jianliang ^a   Pickup, Stephen ^a   Ishii, Masaru ^b   Rizi, Rahim R ^a   Rossman, Milton ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

Bleomycin; Hyperpolarized 3He MRI; Idiopathic pulmonary fibrosis; Interstitial lung disease

Indexed keywords

BLEOMYCIN; HELIUM;

3HE MAGNETIC RESONANCE IMAGING; AIRWAY RESISTANCE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CLINICAL ASSESSMENT; CONTROLLED STUDY; FIBROSING ALVEOLITIS; FORCED EXPIRATORY VOLUME; HISTOLOGY; LUNG COMPLIANCE; LUNG STRUCTURE; LUNG VENTILATION; MALE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RAT; TOTAL LUNG CAPACITY;

ANIMALS; DISEASE MODELS, ANIMAL; HELIUM; HUMANS; IDIOPATHIC PULMONARY FIBROSIS; IMAGE INTERPRETATION, COMPUTER-ASSISTED; ISOTOPES; LUNG; MAGNETIC RESONANCE IMAGING; MALE; PULMONARY VENTILATION; RADIOPHARMACEUTICALS; RATS; RATS, SPRAGUE-DAWLEY; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY;

EID: 77957679793     PISSN: 10766332     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.acra.2010.06.019     Document Type: Article

References (36)

1. Coultas D.B., Zumwalt R.E., Black W.C., Sobonya R.E. The epidemiology of interstitial lung diseases. Am J Respir Crit Care Med 1994, 150:967-972.
2. Raghu G., Brown K.K., Bradford W.Z., et al. A placebo-controlled trial of interferon gamma-1b in patients with idiopathic pulmonary fibrosis. N Engl J Med 2004, 350:125-133. Idiopathic Pulmonary Fibrosis Study Group.
3. Azuma A., Nukiwa T., Tsuboi E., et al. Placebo-controlled trial of pirfenidone in patients with idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 2005, 171:1040-1047.
4. King T.E., Behr J., Brown K.K., et al. BUILD-1: a randomized placebo-controlled trial of bosentan in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 2008, 177:75-81.
5. Visscher D.W., Myers J.L. Histologic spectrum of idiopathic interstitial pneumonias. Proc Am Thorac Soc 2006, 3:322-329.
6. Selman M., King T.E.J., Pardo A. Idiopathic pulmonary fibrosis: prevailing and evolving hypotheses about its pathogenesis and implications for therapy. Ann Intern Med 2001, 134:136-151.
7. Martinez F.J., Safrin S., Weycker D., et al. The clinical course of patients with idiopathic pulmonary fibrosis. Ann Intern Med 2005, 142:963-967. IPF Study Group.
8. Eaton T., Young P., Milne D., Wells A.U. Six-minute walk, maximal exercise tests. reproducibility in fibrotic interstitial pneumonia. Am J Respir Crit Care Med 2005, 171:1150-1157.
9. Mugler J.P., Wang C., Miller G.W., et al. Helium-3 diffusion MR imaging of the human lung over multiple time scales. Acad Radiol 2008, 15:693-701.
10. Parraga G., Mathew L., Etemad-Rezai R., McCormack D.G., Santyr G.E. Hyperpolarized 3He magnetic resonance imaging of ventilation defects in healthy elderly volunteers: initial findings at 3.0 Tesla. Acad Radiol 2008, 15:776-785.
11. Fain S.B., Korosec F.R., Holmes J.H., O'Halloran R., Sorkness R.L., Grist T.M. Functional lung imaging using hyperpolarized gas MRI. J Magn Reson Imaging 2007, 25:910-923.
12. 3He MRI. Magn Reson Med 2004, 52:65-72.
13. Conradi M.S., Yablonskiy D.A., Woods J.C., et al. The role of collateral paths in long-range diffusion of 3He in lungs. Acad Radiol 2008, 15:675-682.
14. Mathew L., Evans A., Ouriadov A., et al. Hyperpolarized 3He magnetic resonance imaging of chronic obstructive pulmonary disease: reproducibility at 3.0 tesla. Acad Radiol 2008, 15:1298-1311.
15. Yu J., Rajaei S., Ishii M., et al. Measurement of pulmonary partial pressure of oxygen and oxygen depletion rate with hyperpolarized helium-3 MRI: a preliminary reproducibility study on pig model. Acad Radiol 2008, 15:702-712.
16. Yablonskly D.A., Sukstanskii A.L., Woods J.C., et al. Quantification of lung microstructure with hyperpolarized 3He diffusion MRI. J Appl Physiol 2009, 107:1258-1265.
17. 3He MRI. Magn Reson Med 2002, 48:223-232.
18. Fain S.B., Gonzalez-Fernandez G., Peterson E.T., et al. Evaluation of structure-function relationships in asthma using multidetector CT and hyperpolarized He-3 MRI. Acad Radiol 2008, 15:753-762.
19. Walker T.G., Happer W. Spin-exchange optical pumping of noble-gas nuclei. Rev Mod Phys 1997, 69:629-642.
20. Emami K., Kadlecek S.J., Woodburn J.M., et al. Improved technique for measurement of regional fractional ventilation by hyperpolarized 3He MRI. Magn Reson Med 2010, 63:137-150.
21. 2. Phys Rev A 1995, 52:862-865.
22. Emami K, Kadlecek S, Pickup S, et al. An improved technique for measurement of gas diffusion anisotropy in lung. Available at: Accessed August 2, 2010. http://crater.imaging.robarts.ca/wiki/images/1/1c/02786.pdf.
23. Neeman M., Freyer J.P., Sillerud L.O. A simple method for obtaining cross-term-free images for diffusion anisotropy studies in NMR microimaging. Magn Reson Med 1991, 21:138-143.
24. Massaro G.D., Massaro D. Retinoic acid treatment abrogates elastase-induced pulmonary emphysema in rats. Nat Med 1997, 3:675-677.
25. Churg A., Hobson J., Wright J. Functional and morphologic comparison of silica- and elastase-induced airflow obstruction. Exp Lung Res 1989, 15:813-822.
26. Moeller A., Ask K., Warburton D., Gauldie J., Kolb M. The bleomycin animal model: a useful tool to investigate treatment options for idiopathic pulmonary fibrosis?. Int J Biochem Cell Biol 2008, 40:362-382.
27. Noble P.W., Homer R.J. Back to the future: historical perspective on the pathogenesis of idiopathic pulmonary fibrosis. Am J Respir Cell Mol Biol 2005, 33:113-120.
28. Aono Y., Nishioka Y., Inayama M., et al. Imatinib as a novel antifibrotic agent in bleomycin-induced pulmonary fibrosis in mice. Am J Respir Crit Care Med 2005, 171:1279-1285.
29. Park S.H., Saleh D., Giaid A., Michel R.P. Increased endothelin-1 in bleomycin-induced pulmonary fibrosis and the effect of an endothelin receptor antagonist. Am J Respir Crit Care Med 1997, 156:600-608.
30. Günther A., Lübke N., Ermert M., et al. Prevention of bleomycin-induced lung fibrosis by aerosolization of heparin or urokinase in rabbits. Am J Respir Crit Care Med 2003, 168:1358-1365.
31. Pinart M., Serrano-Mollar A., Llatjós R., Rocco P.R., Romero P.V. Single and repeated bleomycin intratracheal instillations lead to different biomechanical changes in lung tissue. Respir Physiol Neurobiol 2009, 166:41-46.
32. Fain S.B., Panth S.R., Evans M.D., et al. Early emphysematous changes in asymptomatic smokers: detection with 3He MR imaging. Radiology 2006, 239:875-883.
33. Yu J., Law M., Kadlecek S., et al. Simultaneous measurement of pulmonary partial pressure of oxygen and apparent diffusion coefficient by hyperpolarized 3He MRI. Magn Reson Med 2009, 61:1015-1021.
34. Haczku A., Emami K., Fischer M.C., et al. Hyperpolarized 3He MRI in asthma measurements of regional ventilation following allergic sensitization and challenge in mice-preliminary results. Acad Radiol 2005, 12:1362-1370.
35. Mata J.F., Altes T.A., Cai J., et al. Evaluation of emphysema severity and progression in a rabbit model: comparison of hyperpolarized 3He and 129Xe diffusion MRI with lung morphometry. J Appl Physiol 2007, 102:1273-1280.
36. Demedts M., Behr J., Buhl R., et al. High dose acetylcysteine in idiopathic pulmonary fibrosis. N Engl J Med 2005, 353:2229-2242. IFIGENIA Study Group.